Commit Biologics is a biotechnology company that develops a novel immunotherapy platform, BiCE™, to treat cancer and autoimmune diseases by activating the complement system
Commit Biologics is a biotechnology company that develops a novel immunotherapy platform, BiCE™, to treat cancer and autoimmune diseases by activating the complement system.